Study evaluates biomarker criteria for assessing Alzheimer's risk

(University of Washington School of Medicine/UW Medicine) As a potential framework for assessing an asymptomatic person's risk of developing dementia, the National Institute on Aging and the Alzheimer's Association have endorsed a research tool based on three biomarkers called the AT(N) framework--A, for amyloid, T for tau, and (N) for neurodegeneration or atrophy. However, a new study by researchers in Seattle suggests a subset of people classified by this approach as having the highest risk fo...